Government to support Hanall’s R&D project for new drugs

Hanall Pharm said it will gear up its efforts to develop a novel combination drug containing losartan and amlodipine, backed by the government.

The combination product is based on Hanall’s platform technologies such as xenobiotics and chronotherapy in a bid to ensure better efficacy and less side-effects.

Hanall has already filed its patient applications in 35 countries including Korea. ...